Correct Answer: D. Hepatocellular carcinoma
The clinical presentation of sudden, unintentional weight loss in a chronic alcoholic with markedly elevated alpha-fetoprotein (AFP) of 600 ng/mL is pathognomonic for hepatocellular carcinoma (HCC). While the liver function tests show only mild elevation (ALP 240, direct bilirubin 1 mg/dL, AST/ALT ratio 0.5), the AFP >400 ng/mL is highly specific for HCC in a cirrhotic patient. Chronic alcohol use causes cirrhosis, which is the primary risk factor for HCC development in India. The AST/ALT ratio of 0.5 (AST < ALT) actually suggests ongoing hepatocellular injury rather than advanced fibrosis, but in the context of cirrhosis from chronic alcohol use, HCC can develop with relatively preserved synthetic function. Weight loss is a cardinal paraneoplastic/constitutional symptom of HCC. AFP is the gold standard tumor marker for HCC diagnosis; levels >400 ng/mL in a cirrhotic patient have >95% specificity for HCC. The mild LFT derangement does not exclude HCC—many HCCs arise in compensated cirrhosis with near-normal transaminases.
Why the other options are wrong
A. Alcoholic hepatitis — Alcoholic hepatitis presents with acute hepatic inflammation, typically showing markedly elevated transaminases (AST >> ALT) and hyperbilirubinemia. This patient's AST/ALT ratio of 0.5 (ALT > AST) argues against acute hepatitis. More critically, AFP is normal or mildly elevated in alcoholic hepatitis; an AFP of 600 ng/mL is diagnostic of HCC, not hepatitis. Alcoholic hepatitis does not cause weight loss as a primary feature. B. Cholangiocarcinoma — Cholangiocarcinoma typically presents with obstructive jaundice (markedly elevated direct bilirubin and ALP) and pruritus. This patient has only mild hyperbilirubinemia (1 mg/dL). Crucially, cholangiocarcinoma does not produce AFP; AFP is specific to hepatocellular origin. While cholangiocarcinoma can occur in cirrhotic livers, the AFP elevation makes HCC the diagnosis. Cholangiocarcinoma is not a common complication of alcohol cirrhosis in India. C. Hepatic adenoma — Hepatic adenoma is a benign tumor associated with oral contraceptive use in women, not chronic alcohol use in men. It does not produce AFP and is not a malignant transformation risk in cirrhosis. Adenomas are typically asymptomatic or present with rupture/hemorrhage, not constitutional weight loss. The markedly elevated AFP (600 ng/mL) rules out benign adenoma entirely. Adenoma is not a complication of alcohol cirrhosis.
High-Yield Facts
- AFP >400 ng/mL in a cirrhotic patient = HCC until proven otherwise; sensitivity ~65%, specificity >95%.
- Chronic alcohol use is the leading cause of cirrhosis and HCC in India; HCC can develop with preserved synthetic function (mild LFTs).
- AST/ALT ratio >2 suggests alcoholic liver disease; ratio <1 (ALT > AST) suggests ongoing hepatocellular injury or HCC.
- Constitutional symptoms (weight loss, fatigue, abdominal pain) are paraneoplastic features of HCC, not of hepatitis or benign adenoma.
- HCC screening in cirrhotic patients: AFP + ultrasound every 6 months; CT/MRI for nodules >1 cm with arterial enhancement.
Mnemonics
AFP Cutoff for HCC Diagnosis AFP >400 = HCC in cirrhosis. Below 400 = need imaging. Above 400 = malignancy until proven otherwise. Use when interpreting tumor markers in a cirrhotic patient. AST/ALT Ratio in Liver Disease AST > ALT (ratio >2) = alcoholic hepatitis/fibrosis. ALT > AST (ratio <1) = viral hepatitis or HCC. This patient's 0.5 ratio hints at HCC, not simple alcoholic hepatitis.
NBE Trap
NBE pairs mild LFT elevation with weight loss to lure students into choosing alcoholic hepatitis (which causes transaminitis but not AFP elevation). The AFP of 600 ng/mL is the discriminating fact—students who ignore the tumor marker and focus only on LFTs will miss the diagnosis.
Clinical Pearl
In Indian clinical practice, HCC from alcohol cirrhosis is increasingly common in urban centers. Many patients present late with constitutional symptoms because early HCC is asymptomatic. AFP screening every 6 months in known cirrhotic patients (especially post-alcohol) can catch HCC at a potentially curative stage—this case exemplifies why surveillance matters.
_Reference: Robbins Ch. 20 (Liver and Biliary Tract); Harrison Ch. 84 (Hepatocellular Carcinoma); Bailey & Love Ch. 65 (Liver tumours)_